Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2015 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2014 Net Income-$22.15K-$22.15KN/M vs Q2 2014 EPS Diluted$0.00$0.00— vs Q2 2014 Operating Income-$18,667N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
derived
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end